Jalyn is jointly manufactured by Catalent Pharma Solutions and Rottendorf Pharma. It is distributed by GlaxoSmithKline. Currently, this medication is protected from generic competition by patents that have not yet expired.
When Will a Generic Version Be Available?
The first patent for Jalyn expires in September 2013. This is the earliest predictable date that a generic version could become available.
However, there are other circumstances that could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for specific
Jalyn uses. Once the drug goes off-patent, there may be several companies that manufacture a generic Jalyn drug.
Are Dutasteride and Tamsulosin the Same as Generic Jalyn?
No -- dutasteride and tamsulosin are the active ingredients in Jalyn, but they are not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off-patent, and another company besides the original manufacturer must make the product.
HealthSavvy Sign In
|
